10X Genomics Inc (TXG) — Cash Flow Reinvestment Rate
10X Genomics Inc (TXG) has a Cash Flow Reinvestment Rate of 0.12x as of June 2026, reinvesting $2.04 Million (capex $1.59 Million plus investments $454.00K) from operating cash flow of $16.97 Million. See TXG free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
10X Genomics Inc Cash Flow Reinvestment Rate (2019–2025)
Historical reinvestment intensity for 10X Genomics Inc across 3 annual periods. For the full cash flow conversion analysis, see 10X Genomics Inc (TXG) cash conversion ratio.
Annual Cash Flow Reinvestment Rate for 10X Genomics Inc (2019–2025)
Year-by-year capital reinvestment analysis for 10X Genomics Inc. See financial flexibility index of 10X Genomics Inc to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.06x | $7.70 Million | $136.05 Million | $5.93 Million | ▼ -99.2% |
| 2024 | 6.76x | $45.02 Million | $6.66 Million | $12.39 Million | ▲ +173.5% |
| 2019 | 2.47x | $85.53 Million | $34.63 Million | $42.77 Million | — |